Month: <span>September 2018</span>

Home / 2018 / September
Post

New research: Ketamine activates opioid system to treat depression

Experts caution against widespread use due to a potential for tolerance, abuse, and dependence AMERICAN PSYCHIATRIC ASSOCIATION Washington, D.C., — A new study appearing online today from the American Journal of Psychiatry finds that ketamine’s acute antidepressant effect requires opioid system activation, the first time that a receptor site has been shown in humans to be necessary...

Post

Restless legs syndrome brain stimulation study supports motor cortex ‘excitability’ as a cause

Experiments with patients suggest brain stimulation may be a viable treatment JOHNS HOPKINS MEDICINE Johns Hopkins Medicine researchers say new experiments using magnetic pulse brain stimulation on people with moderate to severe restless legs syndrome (RLS) have added to evidence that the condition is due to excitability and hyperarousal in the part of the brain’s motor cortex...

Post

Failing immune system ‘brakes’ help explain type 1 diabetes in mice

Immune reactions are usually a good thing–the body’s way of eliminating harmful bacteria and other pathogens. But people also rely on molecular “brakes,” or checkpoints, to keep immune systems from attacking their own cells and organs and causing so-called autoimmune disease. Now, working with mice, Johns Hopkins researchers have discovered that in the rodent form...

Post

On the horizon: An acne vaccine

Significant progress made in the development of an acne vaccine using a novel therapeutic approach, according to a new study in the Journal of Investigative Dermatology ELSEVIER Berlin, August 29, 2018 – A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne...

Post

Research brief: Researchers 3D print prototype for ‘bionic eye’

A team of researchers at the University of Minnesota have, for the first time, fully 3D printed an array of light receptors on a hemispherical surface. This discovery marks a significant step toward creating a “bionic eye” that could someday help blind people see or sighted people see better. The research is published today in Advanced Materials, a peer-reviewed scientific...

Post

New way to break cancer’s vicious cycle

University of Toronto researchers have uncovered why some cancers grow faster than others. The team led by Liliana Attisano, Professor in U of T’s Donnelly Centre for Cellular and Biomolecular Research, has identified a protein called NUAK2, which is produced by cancer cells to boost their proliferation and whose presence in tumours is associated with poor disease prognosis....

Post

Newly discovered skull channels play role in immunity

Researchers have now discovered “tiny channels” that allow the injured brain to communicate with bone marrow in the process of inflammation. These “tunnels” are key to ensuring a quick immune response. Inflammation occurs as an immune response to instances of infection or injury within the body. ‘Tiny channels’ in the skull allow injured brain tissue to...

Post

Bladder control via gene therapy?

What are the limits of gene therapy? “There are no currently available FDA-approved gene therapy treatments for overactive bladder,” reads this press release. And that’s true. But is it, like, a problem? Urovant Sciences believes so, which is why it licensed just such a gene therapy for overactive bladder. It’s called hMaxi-K, and it targets...